Key statistics
As of last trade, Edwards Lifesciences Corp (EW:NYQ) traded at 70.03, 18.84% above the 52 week low of 58.93 set on Jul 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 69.65 |
---|---|
High | 70.08 |
Low | 69.16 |
Bid | 69.99 |
Offer | 70.05 |
Previous close | 69.54 |
Average volume | 5.03m |
---|---|
Shares outstanding | 589.80m |
Free float | 584.39m |
P/E (TTM) | 29.37 |
Market cap | 41.01bn USD |
EPS (TTM) | 2.37 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 14:58 GMT.
More ▼
- Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
- TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
- Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
- Edwards Lifesciences Reports Third Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
- Edwards Lifesciences Completes Sale of Critical Care
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
More ▼